BYETTA, also known by its generic name exenatide, is a medication used in the management of type 2 diabetes. It belongs to a class of drugs known as incretin mimetics, which work by mimicking the action of incretin hormones in the body. These hormones are responsible for increasing insulin release in response to high blood sugar levels, thereby helping to lower blood glucose. BYETTA is administered through subcutaneous injections and is typically prescribed when other diabetes medications have not provided adequate blood sugar control. In addition to its blood sugar-lowering effects, BYETTA may also aid in weight loss, making it a beneficial treatment option for patients with type 2 diabetes who are also overweight or obese. However, like all medications, it can have side effects and is not suitable for everyone, including patients with certain types of gastrointestinal disease or those with a history of pancreatitis. When using BYETTA, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medication. This ensures you understand the correct dosage and administration times. Since BYETTA can cause side effects such as dizziness and nausea, which are relatively common, it's advisable to avoid driving or operating heavy machinery until you know how the medication affects you. Less common but more severe side effects include pancreatitis and kidney problems; immediate medical attention is required if you experience symptoms like severe abdominal pain or changes in urination. It's also essential to inform your doctor about all other medications you're taking, as BYETTA can interact with them, potentially leading to adverse effects. Always prioritize safety and open communication with your healthcare provider when using BYETTA.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.